1,451,095 Shares in Grail, Inc. (NASDAQ:GRAL) Purchased by Vanguard Group Inc.

Vanguard Group Inc. acquired a new position in Grail, Inc. (NASDAQ:GRAL) during the fourth quarter, HoldingsChannel reports. The institutional investor acquired 1,451,095 shares of the company’s stock, valued at approximately $25,902,000.

A number of other institutional investors and hedge funds have also made changes to their positions in GRAL. Crcm LP bought a new stake in shares of Grail in the 4th quarter worth approximately $65,061,000. Primecap Management Co. CA bought a new stake in Grail in the fourth quarter worth $37,118,000. Bank of New York Mellon Corp purchased a new stake in shares of Grail in the fourth quarter worth $6,262,000. TCW Group Inc. purchased a new stake in shares of Grail in the fourth quarter worth $5,095,000. Finally, abrdn plc bought a new position in shares of Grail during the fourth quarter valued at $3,768,000.

Insider Buying and Selling

In other news, CEO Robert P. Ragusa sold 7,625 shares of the stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.21, for a total transaction of $237,976.25. Following the transaction, the chief executive officer now directly owns 828,662 shares of the company’s stock, valued at $25,862,541.02. This represents a 0.91 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Aaron Freidin sold 1,816 shares of Grail stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $56,659.20. Following the completion of the sale, the chief financial officer now directly owns 335,170 shares of the company’s stock, valued at $10,457,304. The trade was a 0.54 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 11,550 shares of company stock worth $360,436.

Grail Price Performance

Shares of GRAL opened at $24.85 on Tuesday. Grail, Inc. has a twelve month low of $12.33 and a twelve month high of $63.99. The firm has a 50 day moving average of $33.33 and a 200 day moving average of $23.34.

Grail (NASDAQ:GRAL) last posted its earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, topping analysts’ consensus estimates of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to the consensus estimate of $35.33 million. On average, equities research analysts predict that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, Morgan Stanley upped their price target on shares of Grail from $16.00 to $20.00 and gave the stock an “equal weight” rating in a research note on Tuesday, March 18th.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.